MOD decipher prostate cancer testing
Ended Awarded Last action
- Contract number
- 36C25725N0025
- Awardee
-
Veracyte Labs SD Corporation UEI DKKCNLTYT2A1 Part of Veracyte, Inc.
- Awarding agency
-
Veterans Integrated Service Network 17
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $22,684
Award facts
- Contract value 100% obligated
- $22,684.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- San Antonio, TX 78216, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$42,128 | |
| Original award | $64,812 |
About this award
Veracyte Labs SD Corporation, operating under its Decipher Biosciences, Inc. division, received a $22,684.13 firm fixed-price blanket purchase agreement call from Veterans Integrated Service Network 17 (VISN 17) on November 15, 2024, for the modification of Decipher Prostate Cancer testing services. The contract is scheduled for completion by November 14, 2025, with performance taking place in San Antonio, Texas. This award represents a task order issued under an existing $991,815.95 blanket purchase agreement between VISN 17 and Veracyte Labs SD Corporation that runs through November 2026, both established under the General Services Administration's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract contains no set-aside designation and reflects the specialized, proprietary nature of Veracyte's genomic diagnostic capabilities.
The Decipher Prostate Cancer Test is a genomic classifier that analyzes tumor gene expression patterns to assess cancer risk, aggressiveness, and metastatic potential, enabling clinicians to make informed treatment decisions for veteran populations. This award supports the Department of Veterans Affairs' precision medicine initiatives and personalized cancer care across the VISN 17 network. Veracyte Labs SD Corporation, a subsidiary of parent company Veracyte, Inc., has been actively serving federal healthcare agencies since 2021 and maintains multiple blanket purchase agreements and indefinite delivery contracts across multiple Veterans Integrated Service Networks and the Defense Health Agency for similar genomic testing services.
Quick answers
Who was awarded contract 36C25725N0025?
36C25725N0025 was awarded to Veracyte Labs SD Corporation by Veterans Integrated Service Network 17 (Veterans Health Administration) on November 15, 2024.
How much is contract 36C25725N0025 worth?
The government has obligated $22,684 on 36C25725N0025.
Is contract 36C25725N0025 an order under another contract?
Yes. 36C25725N0025 is a BPA call under 36F79721D0019-36C25722A0004, a blanket purchase agreement, on Medical Laboratory Testing and Analysis Services (FSS-621-II).
Was contract 36C25725N0025 competed?
The extent of competition for 36C25725N0025 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award